Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an update.
Recordati has provided an update on its ongoing share buyback programme, under which it repurchases shares to service existing and future stock option and performance share plans for group management. Between 16 and 20 February 2026, the company bought 54,591 ordinary shares on the EXM market at a weighted average price of €47.6094 per share.
Following these latest transactions, Recordati now holds 5,240,744 treasury shares, representing 2.506% of its share capital. The continued execution of the programme supports the company’s long-term incentive schemes, potentially aligning management interests with those of shareholders and signalling confidence in its equity value.
The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on Borsa Italiana, offering therapies in both general and specialist medicine as well as treatments for rare diseases. The company operates across the full value chain from clinical development to production, marketing and licensing of APIs and finished products, serving around 150 countries in EMEA, the Americas and APAC with more than 4,580 employees.
Average Trading Volume: 319,584
Technical Sentiment Signal: Hold
Current Market Cap: €10.01B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.